MEDISEIV, société de médecine générale
0479.395.873 · rovalta.com · 27/09/2026
MEDISEIV, société de médecine générale
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOMEDISEIV, société de médecine générale is a Private limited company incorporated in 2003. Its registered office is in Virton.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0479.395.873
- Incorporation
- 27/01/2003
- Legal form
- Private limited company
- Registered office
- Avenue Bouvier,St-Mard 104
6762 Virton · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 22 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 149,1 k € | +1.6% | 146,7 k € | -3.0% | 151,3 k € | +1.7% | 148,7 k € | +80.9% | 82,2 k € |
| EBITDA | 149,1 k € | +1.6% | 146,7 k € | -2.6% | 150,6 k € | +4.1% | 144,7 k € | +77.3% | 81,6 k € |
| Operating result | 144,3 k € | +2.4% | 140,9 k € | -1.4% | 142,9 k € | +4.8% | 136,3 k € | +86.2% | 73,2 k € |
| Net result | 98 k € | +19.7% | 81,9 k € | -14.6% | 96 k € | +1543% | 5,8 k € | -59.9% | 14,6 k € |
| Balance sheet | |||||||||
| Equity | 498,8 k € | +5.3% | 473,8 k € | -0.6% | 476,8 k € | +7.2% | 444,9 k € | +19.1% | 373,5 k € |
| Total assets | 574,5 k € | -2.4% | 588,7 k € | -6.2% | 627,4 k € | +17.5% | 533,9 k € | +2.6% | 520,6 k € |
| Cash | 477,1 k € | -1.9% | 486,5 k € | -6.1% | 518,3 k € | +24.4% | 416,6 k € | +7.0% | 389,2 k € |
| Debts | 75,7 k € | -34.2% | 115 k € | -23.7% | 150,6 k € | +69.2% | 89 k € | -39.5% | 147,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20201 active · 1 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Frank SEIVERT | Director | since 23/01/2003 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Frank SEIVERT | Manager | since 23/01/2003 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 07/09/2026 | 05/09/2026 | 28/07/2026 | 01/04/2023 | 20/07/2022 | 31/08/2021 |
| General meeting | 27/08/2026 | 29/08/2026 | 18/06/2024 | 27/03/2023 | 05/07/2022 | 25/08/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 22 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 27/08/2026 | 07/09/2026 | French | |
| Abridged modelCorrection | 31/12/2024 | 29/08/2026 | 05/09/2026 | French | |
| Abridged model | 31/12/2024 | 20/03/2025 | 28/03/2025 | French | |
| Abridged modelCorrection | 31/12/2023 | 18/06/2024 | 28/07/2026 | French | |
| Abridged model | 31/12/2023 | 18/06/2024 | 19/06/2024 | French | |
| Abridged model | 31/12/2022 | 27/03/2023 | 01/04/2023 | English | |
| Abridged model | 31/12/2021 | 05/07/2022 | 20/07/2022 | French | |
| Micro model | 31/12/2020 | 25/08/2021 | 31/08/2021 | French | |
| Micro model | 31/12/2019 | 24/06/2020 | 10/07/2020 | French | |
| Micro model | 31/12/2018 | 26/06/2019 | 29/08/2019 | French | |
| Micro model | 31/12/2017 | 27/06/2018 | 30/08/2018 | French | |
| Micro model | 31/12/2016 | 28/06/2017 | 31/08/2017 | French | |
| Abridged model | 31/12/2015 | 29/06/2016 | 30/08/2016 | French | |
| Abridged model | 31/12/2014 | 24/06/2015 | 31/08/2015 | French | |
| Abridged model | 31/12/2013 | 25/06/2014 | 07/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 26/06/2013 | 29/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 27/06/2012 | 28/12/2012 | Dutch | |
| Abridged model | 31/12/2010 | 29/06/2011 | 31/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 30/06/2010 | 31/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 28/10/2009 | 17/11/2009 | Dutch | |
| Abridged model | 31/12/2007 | 25/06/2008 | 07/07/2008 | French | |
| Abridged model | 31/12/2006 | 27/06/2007 | 20/09/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20201 active · 1 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Frank SEIVERT | Director | since 23/01/2003 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Frank SEIVERT | Manager | since 23/01/2003 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates28/12/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DENOMINATION - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
- Capital / shares12/01/2018CAPITAL, ACTIONS
- Capital / shares07/01/2014CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates15/04/2013DENOMINATION - OBJET
- Other15/12/2003DIVERS
- Other04/02/2003RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202598 k €↑
- 2024Annual accounts 202481,9 k €↓
- 2023Annual accounts 202396 k €↑
- 2023Name changeMEDISEIV, société de médecine générale
- 2022Annual accounts 20225,8 k €↓
- 2021Annual accounts 202114,6 k €↓
- 2020Annual accounts 202073,8 k €↓
- 2019Annual accounts 201984,3 k €↑
- 2018Annual accounts 201864,4 k €↑
- 2017Annual accounts 201715,2 k €↓
- 2016Annual accounts 201649,9 k €↓
- 2015Annual accounts 201555,5 k €↓
- 2014Annual accounts 201455,8 k €↑
- 2013Annual accounts 201342,9 k €↓
- 2012Annual accounts 201252 k €↑
- 2012Name changeMEDISEIV, SOCIETE CIVILE DE MEDECINE GENERALE
- 2011Annual accounts 201147,7 k €↓
- 2010Annual accounts 201049 k €↑
- 2009Annual accounts 200934,2 k €↑
- 2008Annual accounts 200825,7 k €↓
- 2007Annual accounts 200727 k €↑
- 2006Annual accounts 200623,5 k €
- 27/01/2003IncorporationPrivate limited company
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Bouvier,St-Mard 104, 6762 Saint-MardCurrent | accounts 2023 → 2025 · CBE, tracked since 27/09/2026 | Accounts 2025 · 2026-00504999 |
| Avenue Bouvier 104, 6760 Virton | accounts 2023 | Accounts 2023 · 2024-00145913 |
| Avenue Bouvier,St-Mard 104, 6762 Saint-Mard | accounts 2021 → 2022 | Accounts 2022 · 2023-00052355 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| MEDISEIV, société de médecine généraleCurrent | accounts 2023 → 2025 · CBE, tracked since 27/09/2026 | Accounts 2025 · 2026-00504999 |
| MEDISEIV, SOCIETE CIVILE DE MEDECINE GENERALE | accounts 2012 → 2022 | Accounts 2022 · 2023-00052355 |
| MEDISEIV | accounts 2006 → 2011 | Accounts 2011 · 2012-68100324 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.